Difficulty: Medium
Average Score: 71%
Practice
In vomiting induced by cancer chemotherapy, the following is least likely used
Correct answer
C
Rationale
In the context of cancer chemotherapy-induced vomiting, the least likely option used is Loratadine (Option C).
The correct answer, Loratadine, is an antihistamine primarily used for allergic conditions. It is not indicated for the management of chemotherapy-induced nausea and vomiting (CINV). In contrast, the other options are commonly used in the management of CINV.
Metoclopramide (Option A) is a prokinetic agent that helps in reducing nausea and vomiting by increasing gastric emptying. Ondansetron + Diazepam (Option B) is a combination that includes an antiemetic (Ondansetron) and an anxiolytic (Diazepam) to address both nausea and anxiety associated with chemotherapy. Ondansetron + Corticosteroids (Option D) is a potent combination often used to prevent and manage CINV in patients undergoing chemotherapy.
In an educational context, understanding the appropriate pharmacological interventions for managing side effects of chemotherapy is crucial for healthcare providers. It is essential to differentiate between drugs used for specific indications to ensure optimal patient care and outcomes. This question highlights the importance of selecting the most appropriate medication based on the clinical scenario and understanding the mechanisms of action of different drug classes in managing chemotherapy-induced symptoms.
The correct answer, Loratadine, is an antihistamine primarily used for allergic conditions. It is not indicated for the management of chemotherapy-induced nausea and vomiting (CINV). In contrast, the other options are commonly used in the management of CINV.
Metoclopramide (Option A) is a prokinetic agent that helps in reducing nausea and vomiting by increasing gastric emptying. Ondansetron + Diazepam (Option B) is a combination that includes an antiemetic (Ondansetron) and an anxiolytic (Diazepam) to address both nausea and anxiety associated with chemotherapy. Ondansetron + Corticosteroids (Option D) is a potent combination often used to prevent and manage CINV in patients undergoing chemotherapy.
In an educational context, understanding the appropriate pharmacological interventions for managing side effects of chemotherapy is crucial for healthcare providers. It is essential to differentiate between drugs used for specific indications to ensure optimal patient care and outcomes. This question highlights the importance of selecting the most appropriate medication based on the clinical scenario and understanding the mechanisms of action of different drug classes in managing chemotherapy-induced symptoms.